Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Heinemann

Showing results (11-20 of 185) with videos related to

Pageof 19
Sort By:
Anticancer Research|March 1, 1993
Phase II-study for treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrineU Jehn, V Heinemann
Annals of Hematology|March 1, 1993
Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrineU Jehn, V Heinemann
Haematology and Blood Transfusion|January 1, 1990
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogeneous leukemiaU Jehn, V Heinemann
Der Internist|July 25, 2000
[Age factors in cancer therapy]V Heinemann, W Hiddemann
Der Internist|April 20, 2002
[Current treatment strategies in breast carcinoma]V Heinemann, W Hiddemann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Perioperative management of pancreatic cancerV Heinemann, S Boeck
Annals of Hematology|October 1, 1991
Acute myeloid leukemia in the elderly: biological features and search for adequate treatmentV Heinemann, U Jehn
MMW Fortschritte Der Medizin|April 28, 2009
[Actual achievements in the therapy of hepatic metastases in patients with colorectal cancer]V Heinemann, F Löhe
Mycoses|January 1, 1994
[Comparative study on the pharmacokinetics of various amphotericin B preparations]V Heinemann, U Jehn
Anticancer Research|March 1, 1991
New drugs in the treatment of acute and chronic leukemia with some emphasis on m-AMSAU Jehn, V Heinemann
Pageof 19

Showing results (11-20 of 185) with videos related to

Sort By:
Pageof 19
Anticancer Research|March 1, 1993
Phase II-study for treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrineU Jehn, V Heinemann
Annals of Hematology|March 1, 1993
Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytosine arabinoside and amsacrineU Jehn, V Heinemann
Haematology and Blood Transfusion|January 1, 1990
Intermediate-dose Ara-C/m-AMSA for remission induction and high-dose Ara-C/m-AMSA for intensive consolidation in relapsed and refractory adult acute myelogeneous leukemiaU Jehn, V Heinemann
Der Internist|July 25, 2000
[Age factors in cancer therapy]V Heinemann, W Hiddemann
Der Internist|April 20, 2002
[Current treatment strategies in breast carcinoma]V Heinemann, W Hiddemann
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2008
Perioperative management of pancreatic cancerV Heinemann, S Boeck
Annals of Hematology|October 1, 1991
Acute myeloid leukemia in the elderly: biological features and search for adequate treatmentV Heinemann, U Jehn
MMW Fortschritte Der Medizin|April 28, 2009
[Actual achievements in the therapy of hepatic metastases in patients with colorectal cancer]V Heinemann, F Löhe
Mycoses|January 1, 1994
[Comparative study on the pharmacokinetics of various amphotericin B preparations]V Heinemann, U Jehn
Anticancer Research|March 1, 1991
New drugs in the treatment of acute and chronic leukemia with some emphasis on m-AMSAU Jehn, V Heinemann
Pageof 19